Richard J Pastor

age ~66

from Oakland, CA

Get Report

Also known as:

Richard Joseph Pastor
Dick Pastor
Rick Pastor

Phone and address:: 3321 Courtland Ave, Oakland, CA 94619
5105351629

Connected to:

Richard Pastor Phones & Addresses

3321 Courtland Ave, Oakland, CA 94619 • 5105351629
Clayton, CA
1415 Broadway, Alameda, CA 94501 • 5108147383
Liverpool, NY
San Francisco, CA
PO Box 236, Alameda, CA 94501 • 5106730181

Work

Position:

Protective Service Occupations

Education

Degree:

High school graduate or higher

Emails

r***[email protected]

Us Patents

Serine Protease Inhibitors
view source
US Patent:

6472393, Oct 29, 2002
Filed:

Mar 21, 2000
Appl. No.:

09/509104
Inventors:

Dean R. Artis - Kensington CA
Michael S. Dina - Daly City CA
John A. Flygare - Burlingame CA
Richard A. Goldsmith - Daly City CA
Regina A. Munroe - San Mateo CA
Alan G. Olivero - Half Moon Bay CA
Richard Pastor - San Francisco CA
Thomas E. Rawson - Mountain View CA
Kirk D. Robarge - San Francisco CA
Daniel P. Sutherlin - San Carlos CA
Kenneth J. Weese - South San Francisco CA
Aihe Zhou - San Jose CA
Yan Zhu - Foster City CA
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 3118
US Classification:

514247, 51425502, 514447, 514542, 514562, 514601, 514602, 514603, 514604, 514616, 514628, 514630, 544244, 546306, 549 65, 560 13, 562430, 564 82, 564 84, 564 86, 564 87, 564 89, 564 91, 564 92, 564 99, 564212, 564213, 564220
Abstract:

Compounds having the structure shown below wherein A, B, N , N , X, Y, Q, R , R and R are as defined herein are useful to inhibit serine protease enzymes, such as TF/factor VIIa factor Xa, thrombin and kallikrein. These compounds may be used in methods of preventing and/or treating clotting disorders.

Amidine Inhibitors Of Serine Proteases
view source
US Patent:

6838479, Jan 4, 2005
Filed:

Sep 5, 2001
Appl. No.:

10/363557
Inventors:

Richard M Pastor - San Francisco CA, US
Dean R. Artis - Kensington CA, US
Alan G. Olivero - Half Moon Bay CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 3140
C07D20712
US Classification:

514423, 548537, 548532, 548518, 548465, 546146, 546208, 5462784, 544372, 514422, 514414, 514340, 514326, 514307, 514252
Abstract:

Inhibitors of serine proteases are provided having formula (I) wherein X, R, R, R, Rand Rare as defined herein. In particular, the compounds bind to factor VIIa, tissue factor/factor Xa complex, thrombin, trypsin, plasmin and kallikrein and have anticoagulant activity. Pharmaceutical compositions comprising the compounds are useful for inhibiting the formation of veinous and/or arterial thrombi in vivo.

Serine Protease Inhibitors
view source
US Patent:

6919369, Jul 19, 2005
Filed:

Aug 19, 2002
Appl. No.:

10/224114
Inventors:

Dean R. Artis - Kensington CA, US
Michael S. Dina - Daly City CA, US
John A. Flygare - Burlingame CA, US
Richard A. Goldsmith - Daly City CA, US
Regina A. Munroe - San Mateo CA, US
Alan G. Olivero - Half Moon Bay CA, US
Richard Pastor - San Francisco CA, US
Thomas E. Rawson - Mountain View CA, US
Kirk D. Robarge - San Francisco CA, US
Daniel P. Sutherlin - San Carlos CA, US
Kenneth J. Weese - South San Francisco CA, US
Aihe Zhou - San Jose CA, US
Yan Zhu - Foster City CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K031/18
C07C311/05
US Classification:

514445, 514539, 514562, 514601, 514602, 514603, 514604, 514605, 549 63, 549 65, 560 13, 562430, 564 80, 564 84, 564 86, 564 87, 564 91, 564 92, 564 99
Abstract:

Compounds having the structure shown below are useful to inhibit serine protease enzymes, such as TF/factor VIIa, factor Xa, thrombin and kallikrein. These compounds may be used in methods of preventing and/or treating clotting disorders.

Integrase Inhibitors
view source
US Patent:

8008287, Aug 30, 2011
Filed:

May 16, 2007
Appl. No.:

11/804041
Inventors:

Zhenhong R. Cai - Foster City CA, US
Salman Y. Jabri - San Francisco CA, US
Haolun Jin - Foster City CA, US
Rachael A. Lansdown - San Francisco CA, US
Samuel E. Metobo - Newark CA, US
Michael R. Mish - La Honda CA, US
Richard M. Pastor - San Francisco CA, US
Assignee:

Gilead Sciences, Inc. - Foster City CA
International Classification:

A61K 31/54
A01N 43/58
A01N 43/60
C07D 471/00
C07D 487/00
C07D 401/00
US Classification:

514196, 5142228, 514250, 544346, 544361
Abstract:

Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.

Triazolopyridine Jak Inhibitor Compounds And Methods
view source
US Patent:

8609687, Dec 17, 2013
Filed:

May 14, 2012
Appl. No.:

13/471269
Inventors:

Bing-Yan Zhu - Palo Alto CA, US
Michael Siu - Burlingame CA, US
Steven R. Magnuson - Dublin CA, US
Richard Pastor - San Francisco CA, US
He Haiying - Shanghai, CN
Xiao Yisong - Shanghai, CN
Zheng Jifu - Shanghai, CN
Xu Xing - Chengdu, CN
Zhao Junping - Yanan, CN
Christopher Hurley - Hertfordshire, GB
Jun Liang - Palo Alto CA, US
Wendy Liu - Foster City CA, US
Joseph P. Lyssikatos - Piedmont CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 31/437
C07D 471/02
US Classification:

514303, 546119
Abstract:

A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R, R, R, Rand Rare defined herein, are useful as JAK kinase inhibitors. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of JAK kinase activity in a patient are disclosed.

Pyrazolopyrimidine Jak Inhibitor Compounds And Methods
view source
US Patent:

8637526, Jan 28, 2014
Filed:

May 2, 2011
Appl. No.:

13/099179
Inventors:

Jeffrey Blaney - Piedmont CA, US
Paul A. Gibbons - San Francisco CA, US
Emily Hanan - Redwood City CA, US
Joseph P. Lyssikatos - Piedmont CA, US
Steven R. Magnuson - Dublin CA, US
Richard Pastor - San Francisco CA, US
Thomas E. Rawson - Mountain View CA, US
Aihe Zhou - San Jose CA, US
Bing-Yan Zhu - Palo-Alto CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A01N 43/90
A61K 31/519
C07D 487/00
US Classification:

5142593, 544281
Abstract:

The invention provides JAK kinase inhibitors of Formula Ia, enantiomers, diasteriomers or pharmaceutically acceptable salts thereof, wherein R, R, Rand Z are defined herein, a pharmaceutical composition that includes a compound of Formula Ia and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a JAK kinase activity in a patient.

Amidine Inhibitors Of Serine Proteases
view source
US Patent:

20020055469, May 9, 2002
Filed:

Sep 5, 2001
Appl. No.:

09/947424
Inventors:

Richard Pastor - San Francisco CA, US
Dean Artis - Kensington CA, US
Alan Olivero - Half Moon Bay CA, US
Assignee:

GENENTECH, INC.
International Classification:

A61K038/05
A61K031/401
C 07D 4 3/02
C07K005/078
US Classification:

514/019000, 514/422000, 514/423000, 548/517000, 548/535000
Abstract:

Inhibitors of serine proteases are provided having formula (I) wherein X, R, R, R, Rand Rare as defined herein. In particular, the compounds bind to factor VIIa, tissue factor/factor Xa complex, thrombin, trypsin, plasmin and kallikrein and have anticoagulant activity. Pharmaceutical compositions comprising the compounds are useful for inhibiting the formation of veinous and/or arterial thrombi in vivo.

Serine Protease Inhibitors
view source
US Patent:

20050186198, Aug 25, 2005
Filed:

Mar 24, 2005
Appl. No.:

11/088511
Inventors:

Dean Artis - Kensington CA, US
Michael Dina - Daly City CA, US
John Flygare - Burlingame CA, US
Richard Goldsmith - Daly City CA, US
Regina Munroe - San Mateo CA, US
Alan Olivero - Half Moon Bay CA, US
Richard Pastor - San Francisco CA, US
Thomas Rawson - Mountain View CA, US
Kirk Robarge - San Francisco CA, US
Daniel Sutherlin - San Carlos CA, US
Kenneth Weese - South San Francisco CA, US
Aihe Zhou - San Jose CA, US
Yan Zhu - Foster City CA, US
International Classification:

A61K038/48
A61K031/60
A61K031/54
A61K031/445
A61K031/18
US Classification:

424094640, 514165000, 514227500, 514237500, 514252120, 514317000, 514365000, 514374000, 514397000, 514602000, 514457000
Abstract:

Compounds having the structure shown below are useful to inhibit serine protease enzymes, such as TF/factor VIIa, factor Xa, thrombin and kallikrein. These compounds may be used in methods of preventing and/or treating clotting disorders.